GC
OME

Globeflex Capital’s Omega Protein OME Stock Holding History

Globeflex Capital’s Portfolio OME Stock Details OME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-52
Closed -$1K – 440
2017
Q2 		$1K Hold
52
– – ﹤0.01% 410
2017
Q1 		$1K Hold
52
– – ﹤0.01% 462
2016
Q4 		$1K Hold
52
– – ﹤0.01% 468
2016
Q3 		$1K Hold
52
– – ﹤0.01% 463
2016
Q2 		$1K Hold
52
– – ﹤0.01% 436
2016
Q1 		$1K Buy
52
+7
+16% +$143 ﹤0.01% 428
2015
Q4 		$1K Sell
45
-17,897
-100% -$373K ﹤0.01% 426
2015
Q3 		$304K Hold
17,942
– – 0.07% 335
2015
Q2 		$247K Buy
17,942
+24
+0.1% +$319 0.05% 363
2015
Q1 		$245K Sell
17,918
-99
-0.5% -$1.14K 0.05% 344
2014
Q4 		$190K Hold
18,017
– – 0.04% 361
2014
Q3 		$225K Buy
+18,017
New +$251K 0.03% 341
2014
Q1 		– Sell
-114
Closed -$1K – 728
2013
Q4 		$1K Buy
+114
New +$1.34K ﹤0.01% 575

Other funds holding OME

Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
FM
Fondren Management Houston, Texas $16.9M AUM 5.82% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Globeflex Capital's OME Position: Q3 2017 in Review

Globeflex Capital sold out of Omega Protein (OME) in Q3 2017, closing a stake of 52 shares — an estimated $1K sold.

Globeflex Capital first reported a position in OME in Q4 2013 and held it in 13 quarters. The position peaked at $304K in Q3 2015. 122 funds tracked by Wall St. Rank hold OME as of Q3 2017.

  • Globeflex Capital reported no remaining Omega Protein position as of Q3 2017 after selling out during the quarter.
  • Globeflex Capital sold 52 Omega Protein shares in Q3 2017, an estimated $1K.
  • Globeflex Capital first reported a position in Omega Protein in Q4 2013 and held it in 13 quarters.
  • Globeflex Capital's Omega Protein position peaked at $304K in Q3 2015.
  • 122 funds tracked by Wall St. Rank held Omega Protein as of Q3 2017.

Based on Globeflex Capital's 13F filing for Q3 2017, filed 13 Nov 2017.